Healthcare -
Biotechnology - NASDAQ - US
$ 7.945
0.953 %
$ 1.65 B
Market Cap
-13.02
P/E
Price Target
Average
63.62%
Revenue Forecast
Estimate
34.72%
EBIT
Estimate
--79.04%
Net Income
Estimate
41.26%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioCryst Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for BCRX of $13 , with forecasts ranging from
a
low of
$7 to a high of $25 .
BCRX Lowest Price Target
Wall Street Target
7 USD
-11.89%
BCRX Average Price Target
Wall Street Target
13 USD
63.62%
BCRX Highest Price Target
Wall Street Target
25 USD
214.66%
REVENUE FORECAST
Revenue Forecast Chart BCRX
EBIT FORECAST
EBIT Forecast Chart BCRX
NET INCOME FORECAST
Net Income Chart BCRX